(Q58009818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Steady-state kinetics and dynamics of morphine in cancer patients: is sedation related to the absorption rate of morphine? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Lona Louring Christrup

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Adrian Banning

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Annette Kjær Ersbøll

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

P Sjøgren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

N H Jensen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Elbaek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pain and Symptom Management

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

164-173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

Morphine glucuronidation in human fetal and adult liver

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Morphine kinetics in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Morphine metabolism in cancer patients on increasing oral doses--no evidence for autoinduction or dose-dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Controlled release morphine sulphate tablets--a study in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Controlled-release morphine tablets. A double-blind trial in dental surgery patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Controlled-release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide after intravenous and oral administration to healthy volunteers: relationship to nonanalgesic actions

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Explanation for potency of repeated oral doses of morphine?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

1 reference

7 January 2021

Morphine-6-Glucuronide: Receptor Binding Profile in Bovine Caudate Nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Morphine-6-glucuronide and Morphine: popioid Receptor Binding and Effects on Dopamine-Sensitive Adenylate Cyclase in Striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Analgesic activity of morphine-6-glucuronide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

The analgesic activity of morphine-6-glucuronide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Morphine-6-glucuronide has high affinity for the opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Intrathecal high dose morphine produces hyperalgesia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Potential analgesic contribution from morphine-6-glucuronide in CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900068-8

7 January 2021

10.1016/S0885-3924(99)00068-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10517037%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference